glycyl-l-phenylalanine has been researched along with alanylproline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, GR; Waller, CL | 1 |
| Bambal, RB; Bishop, PB; Bourgeat, P; Chan, SM; Ganellin, CR; Law, JK; Luthra, PM; Marabout, B; Moore, AN; Peschard, O; Rose, C; Schwartz, JC; Vargas, F | 1 |
| He, Z; Li, T; Lu, D; Qi, W; Su, R; Wu, S | 1 |
3 other study(ies) available for glycyl-l-phenylalanine and alanylproline
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and com
Topics: Angiotensin-Converting Enzyme Inhibitors; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thermolysin | 1993 |
Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.
Topics: Aminopeptidases; Animals; Cerebral Cortex; Dipeptides; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Drug Design; In Vitro Techniques; Oligopeptides; Rats; Serine Endopeptidases; Serine Proteinase Inhibitors; Sincalide; Structure-Activity Relationship | 2000 |
CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Anti-Infective Agents; Models, Molecular; Peptides; Quantitative Structure-Activity Relationship; Regression Analysis; Taste | 2014 |